JPRN-UMIN000047119
Recruiting
N/A
Prospective immune biomarker identification trial for renal cell carcinoma treatment. - Prospective trial for renal cell carcinoma.
ConditionsRenal cell carcinoma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Renal cell carcinoma
- Sponsor
- Keio University, school of medicine
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Biomarker Screening for Immunotherapy Response Evaluation using Microneedle Patch in Patients with Allergic RhinitisDiseases of the respiratory systemKCT0008534Yonsei University Health System, Severance Hospital30
Completed
Phase 3
A Clinical trial of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of ageIRCT20171122037571N4SHIFAPHARMED Industrial Group Co210
Recruiting
N/A
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopeniaJPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50
Completed
N/A
An exploratory biomarker study of immunecheckpoint inhibitors using tumor tissue and peripheral bloodlung cancer, and melanomaJPRN-UMIN000024414Wakayama Medical University120
Recruiting
N/A
Determining prognostic immune markers in patients with ovarian cancer * a prospective explorative cohort study.NL-OMON48676eids Universitair Medisch Centrum300